Yu Feng
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Impacts of early therapy response, interval to therapy interruption, and cumulative therapy interruption duration on outcome of ibrutinib therapy in relapsed/refractory chronic lymphocytic leukemia.
Journal: Annals of hematology
Published: November 01, 2022
Definition and Identification of Patients with Treatment-Resistant Depression in Real-World Clinical Practice Settings Across Asia.
Journal: Neuropsychiatric disease and treatment
Published: May 28, 2020
Management of Treatment-Resistant Depression in Real-World Clinical Practice Settings Across Asia.
Journal: Neuropsychiatric disease and treatment
Published: May 27, 2020
Pharmacokinetic-Pharmacodynamic Characterization of Relapse Risk for Paliperidone Palmitate 1-Month and 3-Month Formulations.
Journal: Journal of clinical psychopharmacology
Published: November 06, 2019
Association between symptom control and functional improvement in patients with acute schizophrenia: A post hoc analysis of an open-label, single-arm, multi-center study of paliperidone-extended release formulation.
Journal: Psychiatry research
Published: December 18, 2018
Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with schizophrenia: subgroup analysis of a global, randomized, double-blind, Phase III, noninferiority study.
Journal: Neuropsychiatric disease and treatment
Published: September 02, 2017
Safety and efficacy of paliperidone palmitate 1-month formulation in Chinese patients with schizophrenia: a 25-week, open-label, multicenter, Phase IV study.
Journal: Neuropsychiatric disease and treatment
Published: August 18, 2017
Paliperidone Palmitate Improves and Maintains Functioning in Asia-Pacific Patients with Schizophrenia.
Journal: Advances in therapy
Published: August 04, 2017
Epidemiology of pharmaceutically treated depression and treatment resistant depression in Taiwan.
Journal: Psychiatry research
Published: September 02, 2016
Efficacy and safety of flexibly dosed paliperidone palmitate in Chinese patients with acute schizophrenia: an open-label, single-arm, prospective, interventional study.
Journal: Neuropsychiatric disease and treatment
Published: July 08, 2015
Enhanced interaction among ErbB4, PSD-95 and NMDAR by chronic MK-801 treatment is associated with behavioral abnormalities.
Journal: Pharmacology, biochemistry, and behavior
Published: October 29, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026